Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Extensive preclinical results described for new NK2 antagonist

Nov. 20, 1997

Beclometasone CFC-free MDI for chronic bronchial asthma approved

Nov. 20, 1997

FDA clears first inhaled corticosteroid for young children with asthma

Nov. 18, 1997

FDA clears new Tilade formulation

Nov. 18, 1997

Pharmacokinetic profile of ciclosporin derivative IMM-125

Nov. 18, 1997

FACET study demonstrates improved asthma control with Pulmicort and Oxis

Nov. 17, 1997

Novartis claims new antiasthmatic agents

Nov. 17, 1997

Pfizer describes new PDE IV inhibitor for asthma

Nov. 14, 1997

First interim phase III safety results reported for OxSODrol

Nov. 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
FDA greenlights Medtronic Onyx subdural hematoma treatment
BioWorld MedTech
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx...